We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis Adds Wyeth To Hemophilia Patent Hit List

Law360 (October 27, 2008, 12:00 AM EDT) -- Swiss drugmaker Novartis AG has filed an amended complaint against Wyeth Pharmaceuticals Inc. in a patent infringement suit over ReFacto and Xyntha hemophilia treatments.

Novartis' California-based vaccines and diagnostics division, Novartis...
To view the full article, register now.